The sustainability of GSCs and progression of glioma rely on the gene that encodes for the Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit (EZH2) (Suvà et al., 2009). This evidence concerns the gene EZH2 and glioma.